1 INTRODUCTION
1.1 REASON OF DOING THIS STUDY
1.2 TARGET AUDIENCES
1.3 MARKET SEGMENTS COVERED IN THIS REPORT

2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF GLOBAL OXYGEN THERAPY MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY
3.1 GLOBAL OXYGEN THERAPY MARKET SNAPSHOT

4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL OXYGEN THERAPY MARKET, BY TYPE
5.1 OVERVIEW
5.2 OXYGEN CONCENTRATORS
5.3 COMPRESSED OXYGEN CYLINDER
5.4 LIQUID OXYGEN SYSTEMS
5.5 HYPERBARIC OXYGEN THERAPY CHAMBER
5.6 OXYGEN MASK
5.7 NASAL CANNULAS

6 GLOBAL OXYGEN THERAPY MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE
6.3 PNEUMONIA
6.4 ASTHMA
6.5 CYSTIC FIBROSIS
6.6 ACUTE RESPIRATORY DISTRESS SYNDROME
6.7 HEMORRHAGE
6.8 SLEEP APNEA
6.9 OTHERS

7 GLOBAL OXYGEN THERAPY MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS & NURSING HOMES
7.3 HOMECARE

8 GLOBAL OXYGEN THERAPY MARKET, BY TRANSPORTABILITY
8.1 OVERVIEW
8.2 PORTABLE DEVICES
8.3 STATIONARY DEVICES

9 GLOBAL OXYGEN THERAPY MARKET, BY GEOGRAPHY
9.1 NORTH AMERICA
9.1.1 MARKET DYNAMICS
9.1.2 U.S.
9.1.3 CANADA
9.1.4 MEXICO
9.2 EUROPE
9.2.1 MARKET DYNAMICS
9.2.2 U.K.
9.2.3 ITALY
9.2.4 FRANCE
9.2.5 GERMANY
9.2.6 RUSSIA
9.2.7 SPAIN
9.2.8 REST OF EUROPE
9.3 ASIA PACIFIC
9.3.1 MARKET DYNAMICS
9.3.2 INDIA
9.3.3 CHINA
9.3.4 JAPAN
9.3.5 AUSTRALIA
9.3.6 REST OF ASIA PACIFIC
9.4 MIDDLE EAST AND AFRICA
9.4.1 MARKET DYNAMICS
9.4.2 GCC
9.4.3 SOUTH AFRICA
9.4.4 REST OF MIDDLE EAST AND AFRICA
9.5 LATIN AMERICA
9.5.1 MARKET DYNAMICS
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA

10 COMPETATIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 PATENT ANALYSIS

11 GLOBAL OXYGEN THERAPY MARKET, BY COMPANY
11.1 INTRODUCTION
11.2 PHILIPS RESPIRONICS
11.2.1 BUSINESS OVERVIEW
11.2.2 PRODUCT & SERVICES
11.2.3 KEY STRATEGY
11.2.4 RECENT DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.3 INOGEN
11.3.1 BUSINESS OVERVIEW
11.3.2 PRODUCT & SERVICES
11.3.3 KEY STRATEGY
11.3.4 RECENT DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.4 CHART INDUSTRIES INC.
11.4.1 BUSINESS OVERVIEW
11.4.2 PRODUCT & SERVICES
11.4.3 KEY STRATEGY
11.4.4 RECENT DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.5 SECHRIST INDUSTRIES INC.
11.5.1 BUSINESS OVERVIEW
11.5.2 PRODUCT & SERVICES
11.5.3 KEY STRATEGY
11.5.4 RECENT DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.6 FISHER & PAYKEL HEALTHCARE
11.6.1 BUSINESS OVERVIEW
11.6.2 PRODUCT & SERVICES
11.6.3 KEY STRATEGY
11.6.4 RECENT DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.7 DEVILBISS HEALTHCARE
11.7.1 BUSINESS OVERVIEW
11.7.2 PRODUCT & SERVICES
11.7.3 KEY STRATEGY
11.7.4 RECENT DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.8 RESMED INC.
11.8.1 BUSINESS OVERVIEW
11.8.2 PRODUCT & SERVICES
11.8.3 KEY STRATEGY
11.8.4 RECENT DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.9 OXYHEALTH LLC
11.9.1 BUSINESS OVERVIEW
11.9.2 PRODUCT & SERVICES
11.9.3 KEY STRATEGY
11.9.4 RECENT DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.10 INVACARE
11.10.1 BUSINESS OVERVIEW
11.10.2 PRODUCT & SERVICES
11.10.3 KEY STRATEGY
11.10.4 RECENT DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.11 PRECISON MEDICAL
11.11.1 BUSINESS OVERVIEW
11.11.2 PRODUCT & SERVICES
11.11.3 KEY STRATEGY
11.11.4 RECENT DEVELOPMENTS
11.11.5 SWOT ANALYSIS
11.12 LUXFER GAS CYLINDERS
11.12.1 BUSINESS OVERVIEW
11.12.2 PRODUCT & SERVICES
11.12.3 KEY STRATEGY
11.12.4 RECENT DEVELOPMENTS
11.12.5 SWOT ANALYSIS
11.13 TAIYO NIPPON SANSO CORPORATION
11.13.1 BUSINESS OVERVIEW
11.13.2 PRODUCT & SERVICES
11.13.3 KEY STRATEGY
11.13.4 RECENT DEVELOPMENTS
11.13.5 SWOT ANALYSIS